Prediction of Distant Recurrence Using EndoPredict Among Women with ER+, HER2- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Martin FilipitsPeter DubskyMargaretha RudasRichard GreilMarija BalicZsuzsanna Bago-HorvathChristian F SingerDominik HlauschekKrystal BrownRyan BernhiselRalf KronenwettJohnathan M LancasterFlorian FitzalMichael GnantPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
This study demonstrates that EPclin can identify patients at low risk for early or late recurrence who may safely forgo adjuvant chemotherapy or extended endocrine therapy, respectively, regardless of nodal status.